PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
5590-5606
Author(s):
Serap Gur, Philip J. Kadowitz, Ege Can Serefoglu and Wayne J.G. Hellstrom
Relaxin, Insulin and Diabetes: An Intriguing Connection
Journal:
Current Diabetes Reviews
Volume:
8
Page:
329-335
Author(s):
Daniele Bani, Alessandro Pini and Samuel Ka-Sheng Yue
Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
10
Page:
190-211
Author(s):
Marie-Ann Ewart and Simon Kennedy
Aldose Reductase, Oxidative Stress and Diabetic Cardiovascular Complications
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
10
Page:
234-240
Author(s):
Srinivasan Vedantham, Radha Ananthakrishnan, Ann Marie Schmidt and Ravichandran Ramasamy
Bidirectional Nature of Cardiovascular and Kidney Disease
Journal:
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume:
12
Page:
168-182
Author(s):
Koichi Shimizu, Hiroshi Nishi, Ayako Shimizu, Takashi Ozawa and Takaaki Senbonmatsu
The Involvement of PPARs in the Causes, Consequences and Mechanisms for Correction of Cardiac Lipotoxicity and Oxidative Stress
Journal:
Current Molecular Pharmacology
Volume:
5
Page:
224-240
Author(s):
M. C. Sugden, M. P. Warlow and M. J. Holness
Use of Clinically Available PPAR Agonists for Heart Failure; Do the Risks Outweigh the Potential Benefits?
Journal:
Current Molecular Pharmacology
Volume:
5
Page:
255-263
Author(s):
Satyam Sarma
Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
2964-2973
Author(s):
Hong Zhou and Yong-jun Li
Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
2828-2860
Author(s):
G. J.S. Cooper
EDITORIAL [Hot Topic: Diabetes Cardiovascular Complications (Guest Editor: Costanza Emanueli)]
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
12
Page:
105-106
Author(s):
Costanza Emanueli